COMPARISON OF FREQUENCY OF SUCCESSFUL TREATMENT IN PATIENTS OF BACTERIAL VAGINOSIS TREATED WITH INTRAVAGINAL METRONIDAZOLE VERSUS INTRAVAGINAL PROBIOTICS
Insights-Journal of Health and Rehabilitation · 2025
DOI: 10.71000/02f63j43 ↗Kurz gefasst
Fachartikel in der Zeitschrift Insights-Journal of Health and Rehabilitation, 2025. Verfasst von Shazia Baloch und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Bacterial vaginosis (BV) is a prevalent vaginal infection caused by an imbalance of lactobacillus-dominated flora and overgrowth of anaerobic bacteria such as Gardnerella vaginalis and Mycoplasma hominis. Standard treatment with intravaginal metronidazole often faces limitations such as recurrence, adverse effects, and poor compliance. Probiotics have emerged as a potential alternative by restoring vaginal microbiota without significant side effects. This study aimed to compare the efficacy of intravaginal probiotics and metronidazole for treating bacterial vaginosis.
Objective
To compare the frequency of successful treatment in patients with bacterial vaginosis treated with intravaginal metronidazole versus intravaginal probiotics.
Methods
This randomized controlled study was conducted over six months at the Department of Obstetrics & Gynecology, Sandeman Provincial Hospital, Quetta. A total of 66 women aged 18-35 years with BV (Nugent score ≥7) were randomly allocated into two groups. The BV-P group received intravaginal probiotics, while the BV-M group received intravaginal metronidazole. Treatment success was defined as the resolution of fishy odor and a Nugent score 0.05). At follow-up, the probiotics group demonstrated a significantly lower Nugent score (2.24 ± 1.50 vs. 3.79 ± 2.52, p = 0.004) and a higher success rate (90.9% vs. 60.6%, p = 0.004). Probiotics maintained superior outcomes across all subgroups.
Conclusion
Intravaginal probiotics showed significantly better efficacy than metronidazole in treating bacterial vaginosis, with improved Nugent scores and treatment success rates. Probiotics represent a viable alternative to traditional antibiotic therapy, providing better patient outcomes with minimal side effects.
Zitieren
APA
Baloch, S., Ghilzai, S., Naz, F., Noor, K., Zahir, K., & Ali, S. (2025). COMPARISON OF FREQUENCY OF SUCCESSFUL TREATMENT IN PATIENTS OF BACTERIAL VAGINOSIS TREATED WITH INTRAVAGINAL METRONIDAZOLE VERSUS INTRAVAGINAL PROBIOTICS. Insights-Journal of Health and Rehabilitation. https://doi.org/10.71000/02f63j43
Vancouver
Baloch S, Ghilzai S, Naz F, Noor K, Zahir K, Ali S. COMPARISON OF FREQUENCY OF SUCCESSFUL TREATMENT IN PATIENTS OF BACTERIAL VAGINOSIS TREATED WITH INTRAVAGINAL METRONIDAZOLE VERSUS INTRAVAGINAL PROBIOTICS. Insights-Journal of Health and Rehabilitation. 2025. doi:10.71000/02f63j43
BibTeX
@article{Baloch2025,
author = {Baloch, Shazia and Ghilzai, Sadia and Naz, Farah and Noor, Kalsoom and Zahir, Khadija and Ali, Sadia},
title = {COMPARISON OF FREQUENCY OF SUCCESSFUL TREATMENT IN PATIENTS OF BACTERIAL VAGINOSIS TREATED WITH INTRAVAGINAL METRONIDAZOLE VERSUS INTRAVAGINAL PROBIOTICS},
journal = {Insights-Journal of Health and Rehabilitation},
year = {2025},
doi = {10.71000/02f63j43}
}
EUVIMED